Portrait of Shriya Srinivasan
Photo: Harvard Bionics Lab · Publisher-directed editorial display; source copyright retained

FigureAsia 35 Under 35 · Science

Shriya Srinivasan

Age 30 · Closed-loop neuroprosthetics · India / United States

Co-first author of a 2025 closed-loop gastrointestinal neuroprosthesis that senses food and modulates motility.

Approximate age at the edition eligibility date
30
Field
Bioengineering
Country or region
India / United States
FigureAsia U35 Assessment
82.1 / 100

Career and documented record

Gastrointestinal disorders are often treated pharmacologically even when the underlying problem is neural control of movement. In a 2025 Nature Communications paper, Shriya Srinivasan and collaborators developed a closed-loop neuroprosthesis that detects food entry and triggers electrochemical stimulation or inhibition of gastrointestinal muscle activity.

The device is designed around feedback: intervention occurs in response to sensed physiological events rather than a fixed schedule. Srinivasan is a first or co-first author and now leads Harvard's BIONICs laboratory, extending the work across neural interfaces and restorative bioengineering.

The platform is preclinical. It does not yet establish durable treatment for gastroparesis, obesity or metabolic disease. Its importance is architectural—a compact loop connecting biological sensing, control and actuation in an organ system difficult to manage precisely.

Why Shriya Srinivasan is on the list

Srinivasan is selected for translating neural-control principles into a complete gastrointestinal device loop. The work is technically integrated, clinically motivated and careful enough to be judged as a platform rather than marketed as a therapy.

The 2025–26 record

GI neuroprosthesis

Co-first-authored a feedback-controlled system coupling food sensing with gastrointestinal stimulation.

Bidirectional control

Demonstrated triggering and inhibition of muscle activity through an electrochemical interface.

BIONICs laboratory

Established an independent Harvard programme in restorative neural interfaces.

The work in its field

Closed-loop bioelectronic medicine must sense a relevant state, decide when to intervene and deliver a controlled effect without damaging tissue. Partial demonstrations are not enough.

Assessment breakdown

82.1out of 100

01

Substantive 2025–2026 contribution

15.6 / 20

Co-first-authored a feedback-controlled system coupling food sensing with gastrointestinal stimulation.

02

Verified scientific impact

11.7 / 15

The Nature Communications study integrates sensing and intervention in a clinically relevant organ system.

03

Originality and distinction

8.4 / 10

The distinction lies in a closed-loop gastrointestinal interface that responds to food entry rather than delivering open-loop stimulation.

04

Field influence

8.1 / 10

Within bioengineering, the work matters because it shifts a live question in closed-loop neuroprosthetics rather than merely attracting attention.

05

Individual agency

8.5 / 10

Srinivasan is a lead author and now principal investigator; the device remains a collaborative engineering result.

06

Durability and trajectory

4.3 / 5

As Assistant Professor of Bioengineering at Harvard John A. Paulson School of Engineering and Applied Sciences, Srinivasan has a platform to carry the work into its next stage.

07

Asian significance and global relevance

4.4 / 5

Indian-American bioengineer whose family and education form a documented South Asian diaspora connection.

08

Evidential validity and reproducibility

6.5 / 8

Preclinical experiments support system function while human therapeutic benefit is explicitly excluded.

09

Advance in scientific knowledge

5.9 / 7

The work demonstrates how gastrointestinal motility can be placed under feedback control through bioelectronic sensing and actuation.

10

Translational or methodological utility

4.4 / 5

The architecture could inform future devices for motility and metabolic disorders after substantial validation.

11

Responsible research stewardship

4.3 / 5

Clinical language remains prospective and long-term implantation risks are stated as unresolved.

Evidence and attribution

Material claims on this page are supported by the edition’s evidence record. FigureAsia tests age, identity, role, result and individual attribution before publication. Public profiles present the reported record; supporting documentation is retained for accuracy review and corrections.

Achievement records
3
Assessment window
2025–26
Editorial status
Included in the 2026 FigureAsia 35 Under 35 edition

Rights and credit

The portrait is published under the rights basis recorded for this edition. Third-party ownership and reuse restrictions remain in force.

Publication status
Published under a documented rights basis
Credit
Harvard Bionics Lab
Licence
Publisher-directed editorial display; source copyright retained
Portrait source and credit